XML 58 R17.htm IDEA: XBRL DOCUMENT v3.20.1
General & Administrative Expenses
12 Months Ended
Dec. 31, 2019
General & Administrative Expenses [Abstract]  
General & Administrative Expenses
Note 11 – General & Administrative Expenses
 
General and Administrative Expenses:
 
(Dollars in thousands)
 
2019
  
2018
  
2017
 
Total Compensation to Employees and Directors
 
$
10,331
  
$
11,289
  
$
11,655
 
Office and Administrative Expenses
  
2,633
   
2,449
   
2,147
 
Audit, Legal and Consultancy
  
1,826
   
1,314
   
3,377
 
Total General and Administrative Expenses
 
$
14,789
  
$
15,052
  
$
17,180
 

Stock Compensation
 
The Company currently maintains the 2019 Incentive Compensation Plan (the “2019 Plan”) for the benefit of directors and senior management.  Different awards may be granted under the 2019 Plan, including stock options, restricted shares/restricted stock units and cash incentive awards.
 
Stock Options
 
The exercise price for options cannot be less than the fair market value of a common stock on the date of grant.
 
Restricted shares
 
Restricted shares can neither be transferred nor assigned by the participant.
 
Vesting conditions
 
Awards issued vest subject to continued employment or office, except that if a member of the board of directors ceases service on the board of directors prior to the applicable vesting date for any reason, his or her restricted stock will immediately vest in full.  The awards have graded vesting.  For some of the awards there is an additional vesting condition requiring certain market conditions to be met.
 
The Plan may allow for different criteria for new grants.
 
Stock Compensation Series
 
  
Number of
shares/options
 
Vesting
Period
 
Fair value
at grant date
 
(1) Granted October 2005, stock options
  
965
 
10 years
 
$
144.00
 
(2) Granted March 2012, restricted shares
  
14,515
 
3 years
  
13.80
 
(3) Granted June 2013, restricted shares
  
155,000
 
4 years
  
4.15
 
(4) Granted June 2013, stock options
  
155,000
 
5 years
  
1.31
 
(5) Granted June 2013, stock options
  
155,000
 
5 years
  
0.97
 
(6) Granted February 2014, restricted shares
  
29,333
 
3 years
  
6.92
 
(7) Granted February 2014, restricted shares
  
29,333
 
3 years
  
6.33
 
(8) Granted February 2014, restricted shares
  
29,333
 
3 years
  
5.63
 
(9) Granted February 2014, restricted shares
  
88,000
 
3 years
  
7.61
 
(10) Granted June 2014, restricted shares
  
95,666
 
3 years
  
6.41
 
(11) Granted June 2014, restricted shares
  
95,666
 
3 years
  
5.74
 
(12) Granted June 2014, restricted shares
  
95,666
 
3 years
  
5.13
 
(13) Granted June 2014, restricted shares
  
287,000
 
3 years
  
7.15
 
(14) Granted January 2015, restricted shares
  
850,000
 
3 years
  
8.81
 
(15) Granted January 2016, restricted shares
  
824,000
 
2 years
  
6.65
 
(16) Granted January 2017, restricted shares
  
900,000
 
2 years
  
4.61
 
(17) Granted January 2018, restricted shares
  
355,000
 
1 year
  
3.92
 
(18) Granted January 2018, restricted shares
  
212,000
 
3 years
  
2.30
 
(19) Granted January 2019, restricted shares
  
360,000
 
3 years
  
4.25
 
(20) Granted January 2019, restricted shares
  
200,000
 
3 years
  
3.04
 
(21) Granted March 2019, restricted shares
  
210,000
 
1 year
 
$
4.60
 

The following reconciles the number of outstanding restricted common stock and share options:
 
 
  
Restricted
common stock
  
Share
options
  
Weighted
average
exercise
price **
 
          
Outstanding at December 31, 2016
  
1,376,820
   
310,000
   
9.64
 
Granted
  
900,000
         
Exercised*
  
1,132,988
         
Forfeited
  
57,501
         
Outstanding at December 31, 2017
  
1,086,331
   
310,000
  
$
9.64
 
             
Outstanding at December 31, 2017
  
1,086,331
   
310,000
   
9.64
 
Granted
  
567,000
         
Exercised*
  
1,085,331
         
Forfeited
  
22,500
   
310,000
   
9.64
 
Outstanding at December 31, 2018
  
545,500
   
-
  
$
-
 
             
Outstanding at December 31, 2018
  
545,500
   
-
   
-
 
Granted
  
770,000
         
Exercised*
  
755,500
         
Forfeited
  
-
         
Outstanding at December 31, 2019
  
560,000
   
-
  
$
-
 
 
*Does not include shares in lieu of dividends
 
**To be adjusted for dividends declared and paid subsequent to the respective grant dates.
 
Stock Compensation Expense
 
(Dollars in thousands)
 
2019
  
2018
  
2017
 
Expense recognized from stock compensation
  
2,532
   
2,458
   
4,806
 
 
The fair value on the vesting date for shares that vested in 2019 was $4.61 for 281,094 shares, $3.92 for 80,101 shares, $2.30 for 212,823 shares, $3.04 for 206,118 shares and $4.60 for 10,435 shares. The fair value on the vesting date for shares that vested in 2018 was $3.38 for 891,136 shares, $3.50 for 264,000 shares and $4.30 for 20,000 shares. The fair value on the vesting date for shares that vested in 2017 was $4.83 for 1,189,100 shares and $3.68 for 70,108 shares. All share-based compensation is equity-settled and no payments were made for the vested shares.  The average contractual life for the outstanding stock compensation series was 0.87 years as of December 31, 2019.
 
Valuation of Stock Compensation
 
For the year 2018, a total of 560,000 shares of restricted stock was awarded to management in January 2019, vesting in equal amounts in January 2020, January 2021 and January 2022, respectively, subject to continued employment or office, as applicable. The calculated fair value at grant date was equal to the share price at grant date. The remaining 200,000 shares vested subject to certain market conditions in May 2019 and the calculated fair value was $3.04 per share. For the year 2018, a total of 210,000 shares of restricted stock were awarded to the board of directors in March 2019. The calculated fair value at grant date was equal to the share price at grant date and the shares will vest in June 2020. For the year 2017, a total of 567,000 shares of restricted stock were awarded to management and the board of directors in January 2018, of which 264,000 shares vested in February 2018 and 78,500 shares vested in February 2019, while 12,500 shares were forfeited in October 2018. The remaining 202,000 shares vested subject to certain market conditions in May 2019, while 10,000 shares were forfeited in October 2018. The above vesting was subject to continued employment or office, as applicable, as of the relevant vesting date, except that if a member of the board of directors ceases service on the board of directors prior to the applicable vesting date for any reason, his or her restricted stock will immediately vest in full. The estimated fair value at grant date was equal to the share price at grant date for 355,000 shares and $2.30 for 212,000 shares.   The grants of restricted stock to management and the board of directors described above were generally granted in the beginning of the year following the year to which they relate.
 
Compensation of Directors and Executives
 
Remuneration of Directors and Executives as a group:
 
(Dollars in thousands)
 
2019
  
2018
  
2017
 
Cash compensation
 
$
3,518
  
$
3,989
  
$
4,171
 
Pension cost
  
36
   
202
   
155
 
Share compensation*
  
2,003
   
2,250
   
4,107
 
Total remuneration
 
$
5,556
  
$
6,441
  
$
8,433
 
 
*Share compensation reflects the expense recognized.
 
Shares held by Directors and Executives:
 
  
2019
  
2018
  
2017
 
Directors and Executives as a group*
  
3,615,221
   
3,155,503
   
2,729,680
 
 
*Includes 440,000 (2018: 465,000, 2017: 906,666) shares of restricted stock subject to vesting conditions.
 
In connection with termination of an Executive’s employment, the Executives of the Company may be entitled to an amount equal to 18 months base salary and any unvested equity awards may become fully vested in certain circumstances.